\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ this\\ patient\\ was\\ assessed\\ as\\ a\\ possible\\ surgical\\ candidate\\,\\ but\\ at\\ the\\ time\\ of\\ this\\ write\\-up\\ had\\ not\\ elected\\ for\\ surgery\\.\\ initial\\ treatment\\ of\\ osteoarthritis\\ is\\ conservative\\,\\ with\\ a\\ goal\\ of\\ pain\\ reduction\\ and\\ minimization\\ of\\ swelling\\ and\\ disability\\.\\ at\\ present\\ there\\ are\\ no\\ pharmacologic\\ therapies\\ that\\ prevent\\ the\\ progression\\ of\\ damage\\ due\\ to\\ osteoarthritis\\.\\ conservative\\ nonpharmacologic\\ therapies\\ include\\ tailored\\ exercise\\ programs\\,\\ weight\\ loss\\ \\(when\\ appropriate\\)\\,\\ and\\ specially\\ designed\\ shoes\\.\\ dietary\\ supplements\\ such\\ as\\ glucosamine\\ and\\ chondroitin\\ may\\ also\\ be\\ useful\\.\\ pharmacologic\\ intervention\\ includes\\ non\\-opioid\\ analgesics\\ and\\ anti\\-inflammatory\\ drugs\\ for\\ long\\-term\\ pain\\ control\\,\\ and\\ in\\ severe\\ cases\\ opiates\\ for\\ acute\\ exacerbations\\.\\ surgical\\ intervention\\ is\\ considered\\ as\\ a\\ final\\ option\\ in\\ patients\\ with\\ severe\\ symptomatic\\ oa\\ of\\ the\\ hip\\ in\\ which\\ medical\\ management\\ is\\ insufficient\\,\\ and\\ there\\ is\\ marked\\ interference\\ with\\ daily\\ activities\\.\\ \\ total\\ hip\\ arthroplasty\\ \\(replacement\\)\\,\\ may\\ provide\\ marked\\ pain\\ relief\\ as\\ well\\ as\\ significant\\ functional\\ improvement\\.\ \(0\)\
\-\ ap\\ and\\ frog\\-leg\\ views\\ of\\ the\\ hips\\ demonstrating\\ marked\\ joint\\ space\\ narrowing\\ bilaterally\\,\\ especially\\ in\\ the\\ superolateral\\ regions\\.\\ \\ there\\ is\\ also\\ evidence\\ of\\ subchondral\\ sclerosis\\ and\\ cyst\\ formation\\.\\ in\\ the\\ superior\\ aspects\\ of\\ the\\ acetabula\\,\\ large\\ osteophytes\\ are\\ present\\ bilaterally\\.\\ \ \(0\)\
\-\ both\\ femoral\\ heads\\ demonstrate\\ contour\\ abnormalities\\ consistent\\ with\\ slipped\\ capital\\ femoral\\ epiphyses\\,\\ the\\ right\\ side\\ greater\\ than\\ the\\ left\\.\\ \ \(0\)\
\-\ there\\ is\\ no\\ evidence\\ of\\ flattening\\ or\\ collapse\\ of\\ the\\ femoral\\ heads\\,\\ and\\ they\\ are\\ well\\ covered\\ by\\ the\\ acetabulum\\.\ \(0\)\
\-\ osteoarthritis\\ of\\ the\\ hips\\ bilaterally\\,\\ secondary\\ to\\ slipped\\ capital\\ femoral\\ epiphyses\\.\ \(0\)\
\-\ osteoarthritis\ \(102\)\
\-\ the\\ patient\\ is\\ a\\ 52\\ year\\-old\\ african\\-american\\ male\\ with\\ bilateral\\ djd\\ secondary\\ to\\ slipped\\ capital\\ femoral\\ epiphyses\\ at\\ a\\ young\\ age\\.\ \(0\)\
\-\ slipped\\ capital\\ femoral\\ epiphysis\\ \\(scfe\\)\\ is\\ the\\ displacement\\ of\\ the\\ epiphysis\\ from\\ the\\ femoral\\ neck\\ at\\ the\\ physeal\\ plate\\.\\ the\\ typical\\ patient\\ is\\ an\\ obese\\ male\\ in\\ early\\ adolescence\\,\\ although\\ it\\ is\\ not\\ uncommon\\ in\\ obese\\ females\\.\\ at\\ presentation\\ nearly\\ 20\\%\\ of\\ cases\\ are\\ bilateral\\ \\(1\\)\\,\\ and\\ of\\ those\\ with\\ a\\ unilateral\\ slip\\ 30\\-60\\%\\ will\\ eventually\\ have\\ a\\ slip\\ in\\ the\\ contralateral\\ hip\\.\\ risk\\ factors\\ include\\ obesity\\,\\ renal\\ failure\\,\\ history\\ of\\ radiation\\ therapy\\,\\ some\\ endocrine\\ abnormalities\\ \\(gh\\ deficiency\\ and\\ hypothyroidism\\)\\,\\ and\\ certain\\ genetic\\ disorders\\ \\(eg\\,\\ down\\ syndrome\\)\\.\\ \\ scfe\\ is\\ caused\\ by\\ shearing\\ forces\\ applied\\ to\\ the\\ femoral\\ head\\ which\\ exceed\\ the\\ strength\\ of\\ the\\ capital\\ physis\\.\\ pain\\ and\\ altered\\ gait\\ are\\ the\\ common\\ presenting\\ complaints\\ of\\ scfe\\.\\ diagnosis\\ can\\ often\\ be\\ made\\ by\\ plain\\ films\\ alone\\.\\ mri\\ may\\ be\\ used\\ for\\ diagnosis\\ when\\ clinical\\ suspicion\\ is\\ high\\ but\\ there\\ is\\ no\\ radiographic\\ evidence\\.\\ in\\ fact\\,\\ mri\\ is\\ quickly\\ becoming\\ the\\ modality\\ of\\ choice\\ in\\ these\\ equivocal\\ cases\\ \\(2\\)\\.\\ patients\\ with\\ a\\ history\\ of\\ scfe\\ have\\ a\\ significantly\\ increased\\ risk\\ of\\ developing\\ osteoarthritis\\ especially\\ if\\ left\\ untreated\\ \\(3\\)\\.\\ the\\ rate\\ of\\ development\\ of\\ osteoarthritis\\ is\\ related\\ to\\ the\\ severity\\ of\\ the\\ slip\\.\\ common\\ radiographic\\ findings\\ of\\ osteoarthritis\\ include\\ asymmetric\\ joint\\ space\\ narrowing\\,\\ osteophytes\\,\\ periartcular\\ sclerosis\\,\\ and\\ subarticular\\ cysts\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.055383679325078\ \(0\)\
\-\ capital\\:\\ 0\\.0522074869318871\ \(0\)\
\-\ femoral\\:\\ 0\\.04852235845737022\ \(0\)\
\-\ scfe\\:\\ 0\\.04381402570746312\ \(0\)\
\-\ slipped\\:\\ 0\\.040405380912718974\ \(0\)\
\-\ slip\\:\\ 0\\.03931208370189427\ \(0\)\
\-\ epiphyses\\:\\ 0\\.03418359079961355\ \(0\)\
\-\ pharmacologic\\:\\ 0\\.025632866697429795\ \(0\)\
\-\ therapies\\:\\ 0\\.021359984964955902\ \(0\)\
\-\ heads\\:\\ 0\\.019320642777015347\ \(0\)\
\-\ osteophytes\\:\\ 0\\.019129249887509556\ \(0\)\
\-\ hip\\:\\ 0\\.019051524470773087\ \(0\)\
\-\ hips\\:\\ 0\\.01877361488823969\ \(0\)\
\-\ marked\\:\\ 0\\.018665370339316267\ \(0\)\
\-\ obese\\:\\ 0\\.018448945571114206\ \(0\)\
\-\ epiphysis\\:\\ 0\\.01749397029448286\ \(0\)\
\-\ write\\-up\\:\\ 0\\.01644686273128078\ \(0\)\
\-\ minimization\\:\\ 0\\.01644686273128078\ \(0\)\
\-\ nonpharmacologic\\:\\ 0\\.01644686273128078\ \(0\)\
\-\ specially\\:\\ 0\\.01644686273128078\ \(0\)\
\-\ glucosamine\\:\\ 0\\.01644686273128078\ \(0\)\
\-\ chondroitin\\:\\ 0\\.01644686273128078\ \(0\)\
\-\ periartcular\\:\\ 0\\.01644686273128078\ \(0\)\
\-\ cases\\:\\ 0\\.015933642895416784\ \(0\)\
\-\ is\\:\\ 0\\.015735749395094933\ \(0\)\
\-\ bilaterally\\:\\ 0\\.01570917111114125\ \(0\)\
\-\ non\\-opioid\\:\\ 0\\.015153677692922673\ \(0\)\
\-\ opiates\\:\\ 0\\.01439721293898953\ \(0\)\
\-\ interference\\:\\ 0\\.01439721293898953\ \(0\)\
\-\ intervention\\:\\ 0\\.014197325111456128\ \(0\)\
\-\ programs\\:\\ 0\\.013860492654564566\ \(0\)\
\-\ tailored\\:\\ 0\\.0134441800588291\ \(0\)\
\-\ designed\\:\\ 0\\.0134441800588291\ \(0\)\
\-\ insufficient\\:\\ 0\\.0134441800588291\ \(0\)\
\-\ include\\:\\ 0\\.013416903850915783\ \(0\)\
\-\ especially\\:\\ 0\\.0131238845426062\ \(0\)\
\-\ adolescence\\:\\ 0\\.013104027900631423\ \(0\)\
\-\ 30\\-60\\:\\ 0\\.013104027900631423\ \(0\)\
\-\ gh\\:\\ 0\\.013104027900631423\ \(0\)\
\-\ supplements\\:\\ 0\\.012816433348714898\ \(0\)\
\-\ shearing\\:\\ 0\\.012816433348714898\ \(0\)\
\-\ narrowing\\:\\ 0\\.012785248858768647\ \(0\)\
\-\ conservative\\:\\ 0\\.012734481500351561\ \(0\)\
\-\ shoes\\:\\ 0\\.012567307616206459\ \(0\)\
\-\ frog\\-leg\\:\\ 0\\.012567307616206459\ \(0\)\
\-\ acetabula\\:\\ 0\\.012567307616206459\ \(0\)\
\-\ exceed\\:\\ 0\\.012567307616206459\ \(0\)\
\-\ evidence\\:\\ 0\\.012539790578545956\ \(0\)\
\-\ subarticular\\:\\ 0\\.012347563146698281\ \(0\)\
\-\ exacerbations\\:\\ 0\\.012150995020470992\ \(0\)\
\-\ djd\\:\\ 0\\.012150995020470992\ \(0\)\
\-\ radiographic\\:\\ 0\\.012102105939510199\ \(0\)\
\-\ as\\:\\ 0\\.012057625987818356\ \(0\)\
\-\ there\\:\\ 0\\.011863018250606237\ \(0\)\
\-\ abnormalities\\:\\ 0\\.011711808289918718\ \(0\)\
\-\ \\,\\:\\ 0\\.011616290124808974\ \(0\)\
\-\ risk\\:\\ 0\\.011549278534921964\ \(0\)\
\-\ superolateral\\:\\ 0\\.01152324831035679\ \(0\)\
\-\ sclerosis\\:\\ 0\\.011452668781441586\ \(0\)\
\-\ elected\\:\\ 0\\.01139453026653785\ \(0\)\
\-\ becoming\\:\\ 0\\.011161016940131123\ \(0\)\
\-\ assessed\\:\\ 0\\.011054378108340175\ \(0\)\
\-\ oa\\:\\ 0\\.01095350642686578\ \(0\)\
\-\ equivocal\\:\\ 0\\.01095350642686578\ \(0\)\
\-\ are\\:\\ 0\\.01086636075120897\ \(0\)\
\-\ arthroplasty\\:\\ 0\\.010857809982112885\ \(0\)\
\-\ at\\:\\ 0\\.010800029410742843\ \(0\)\
\-\ \\(\\:\\ 0\\.010781518302147172\ \(0\)\
\-\ covered\\:\\ 0\\.010766783556423647\ \(0\)\
\-\ applied\\:\\ 0\\.010766783556423647\ \(0\)\
\-\ quickly\\:\\ 0\\.010766783556423647\ \(0\)\
\-\ dietary\\:\\ 0\\.010679992482477951\ \(0\)\
\-\ \\)\\:\\ 0\\.010649816300198582\ \(0\)\
\-\ analgesics\\:\\ 0\\.01059706008962192\ \(0\)\
\-\ space\\:\\ 0\\.010546854504017293\ \(0\)\
\-\ physeal\\:\\ 0\\.010517657823915208\ \(0\)\
\-\ forces\\:\\ 0\\.010517657823915208\ \(0\)\
\-\ untreated\\:\\ 0\\.010517657823915208\ \(0\)\
\-\ may\\:\\ 0\\.01049064385577308\ \(0\)\
\-\ goal\\:\\ 0\\.010368324414076521\ \(0\)\
\-\ joint\\:\\ 0\\.010311303190455527\ \(0\)\
\-\ african\\-american\\:\\ 0\\.010297913354407032\ \(0\)\
\-\ certain\\:\\ 0\\.010230063271998683\ \(0\)\
\-\ anti\\-inflammatory\\:\\ 0\\.010101345228179744\ \(0\)\
\-\ obesity\\:\\ 0\\.009980937539490245\ \(0\)\
\-\ disability\\:\\ 0\\.00992352772854481\ \(0\)\
\-\ activities\\:\\ 0\\.009867831901773016\ \(0\)\
\-\ acetabulum\\:\\ 0\\.009867831901773016\ \(0\)\
\-\ endocrine\\:\\ 0\\.009867831901773016\ \(0\)\
\-\ candidate\\:\\ 0\\.009813750676263217\ \(0\)\
\-\ severe\\:\\ 0\\.009810857462932851\ \(0\)\
\-\ physis\\:\\ 0\\.009611859660143381\ \(0\)\
\-\ eg\\:\\ 0\\.009564624943754778\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.009344880474246602\ \(0\)\
\-\ aspects\\:\\ 0\\.009186003966149013\ \(0\)\
\-\ when\\:\\ 0\\.009131832976179125\ \(0\)\
\-\ altered\\:\\ 0\\.009039601698534286\ \(0\)\
\-\ provide\\:\\ 0\\.008936878233640576\ \(0\)\
\-\ secondary\\:\\ 0\\.008914290919808983\ \(0\)\
\-\ option\\:\\ 0\\.00890385663457453\ \(0\)\
\-\ females\\:\\ 0\\.00887140935339567\ \(0\)\
\-\ drugs\\:\\ 0\\.008808160189821638\ \(0\)\
\-\ long\\-term\\:\\ 0\\.008808160189821638\ \(0\)\
\-\ contralateral\\:\\ 0\\.008808160189821638\ \(0\)\
\-\ functional\\:\\ 0\\.008777321939912663\ \(0\)\
\-\ nearly\\:\\ 0\\.008777321939912663\ \(0\)\
\-\ eventually\\:\\ 0\\.008777321939912663\ \(0\)\
\-\ modality\\:\\ 0\\.00874698514724143\ \(0\)\
\-\ genetic\\:\\ 0\\.008717133764132398\ \(0\)\
\-\ flattening\\:\\ 0\\.008687752501132137\ \(0\)\
\-\ severity\\:\\ 0\\.00865882677998295\ \(0\)\
\-\ alone\\:\\ 0\\.008630342690186702\ \(0\)\
\-\ final\\:\\ 0\\.008602286948834949\ \(0\)\
\-\ deficiency\\:\\ 0\\.008602286948834949\ \(0\)\
\-\ damage\\:\\ 0\\.00852056563790511\ \(0\)\
\-\ 52\\:\\ 0\\.00849410176665146\ \(0\)\
\-\ fact\\:\\ 0\\.008391847594086172\ \(0\)\
\-\ subchondral\\:\\ 0\\.008367136350149566\ \(0\)\
\-\ common\\:\\ 0\\.008344280641628347\ \(0\)\
\-\ developing\\:\\ 0\\.008342748138270175\ \(0\)\
\-\ useful\\:\\ 0\\.008318674621785274\ \(0\)\
\-\ suspicion\\:\\ 0\\.008271439905396671\ \(0\)\
\-\ patients\\:\\ 0\\.008252144027485172\ \(0\)\
\-\ daily\\:\\ 0\\.008248263562115781\ \(0\)\
\-\ choice\\:\\ 0\\.008248263562115781\ \(0\)\
\-\ exercise\\:\\ 0\\.008180413479707433\ \(0\)\
\-\ collapse\\:\\ 0\\.008158334267679443\ \(0\)\
\-\ significantly\\:\\ 0\\.008158334267679443\ \(0\)\
\-\ relief\\:\\ 0\\.008136513297971996\ \(0\)\
\-\ plate\\:\\ 0\\.007990520393308288\ \(0\)\
\-\ by\\:\\ 0\\.007963829682340716\ \(0\)\
\-\ progression\\:\\ 0\\.007931287747198996\ \(0\)\
\-\ prevent\\:\\ 0\\.007911954189296857\ \(0\)\
\-\ unilateral\\:\\ 0\\.007911954189296857\ \(0\)\
\-\ in\\:\\ 0\\.007861888622019681\ \(0\)\
\-\ uncommon\\:\\ 0\\.007799980290553848\ \(0\)\
\-\ pain\\:\\ 0\\.007788120653214438\ \(0\)\
\-\ replacement\\:\\ 0\\.00778195433736031\ \(0\)\
\-\ asymmetric\\:\\ 0\\.0077464166601761775\ \(0\)\
\-\ bilateral\\:\\ 0\\.007738125855650911\ \(0\)\
\-\ contour\\:\\ 0\\.007728898487881701\ \(0\)\
\-\ disorders\\:\\ 0\\.007627109338160742\ \(0\)\
\-\ reduction\\:\\ 0\\.007514975151463531\ \(0\)\
\-\ appropriate\\:\\ 0\\.007514975151463531\ \(0\)\
\-\ improvement\\:\\ 0\\.007438814713925741\ \(0\)\
\-\ \\%\\:\\ 0\\.007437765049798536\ \(0\)\
\-\ gait\\:\\ 0\\.007423948725774292\ \(0\)\
\-\ be\\:\\ 0\\.007375504048566767\ \(0\)\
\-\ mri\\:\\ 0\\.007325656175054551\ \(0\)\
\-\ diagnosis\\:\\ 0\\.007321713920822462\ \(0\)\
\-\ regions\\:\\ 0\\.007295230681955352\ \(0\)\
\-\ control\\:\\ 0\\.007267793839810398\ \(0\)\
\-\ those\\:\\ 0\\.007254225258972563\ \(0\)\
\-\ well\\:\\ 0\\.007212988630480041\ \(0\)\
\-\ present\\:\\ 0\\.0072015252012376145\ \(0\)\
\-\ factors\\:\\ 0\\.007161911719302096\ \(0\)\
\-\ strength\\:\\ 0\\.007073951311791458\ \(0\)\
\-\ the\\:\\ 0\\.00696404978917518\ \(0\)\
\-\ young\\:\\ 0\\.006943597431268164\ \(0\)\
\-\ development\\:\\ 0\\.006943597431268164\ \(0\)\
\-\ demonstrating\\:\\ 0\\.006920845056093129\ \(0\)\
\-\ complaints\\:\\ 0\\.006920845056093129\ \(0\)\
\-\ not\\:\\ 0\\.006911298535869041\ \(0\)\
\-\ have\\:\\ 0\\.0069046196953921335\ \(0\)\
\-\ total\\:\\ 0\\.006865149229321336\ \(0\)\
\-\ down\\:\\ 0\\.00684332825961389\ \(0\)\
\-\ displacement\\:\\ 0\\.006832512741546118\ \(0\)\
\-\ but\\:\\ 0\\.006800385451617677\ \(0\)\
\-\ surgical\\:\\ 0\\.006702320038251692\ \(0\)\
\-\ caused\\:\\ 0\\.006687331729686402\ \(0\)\
\-\ a\\:\\ 0\\.006659325030536216\ \(0\)\
\-\ formation\\:\\ 0\\.006580692897895453\ \(0\)\
\-\ films\\:\\ 0\\.006580692897895453\ \(0\)\
\-\ related\\:\\ 0\\.006580692897895453\ \(0\)\
\-\ views\\:\\ 0\\.006571294028436579\ \(0\)\
\-\ presenting\\:\\ 0\\.00649776050503942\ \(0\)\
\-\ considered\\:\\ 0\\.006435713449523595\ \(0\)\
\-\ includes\\:\\ 0\\.006427015663878424\ \(0\)\
\-\ typical\\:\\ 0\\.006392624429384324\ \(0\)\
\-\ made\\:\\ 0\\.006350508156924363\ \(0\)\
\-\ symptomatic\\:\\ 0\\.006333924299802634\ \(0\)\
\-\ also\\:\\ 0\\.0062858940062319076\ \(0\)\
\-\ failure\\:\\ 0\\.006245257990357028\ \(0\)\
\-\ cysts\\:\\ 0\\.006245257990357028\ \(0\)\
\-\ rate\\:\\ 0\\.0062140326314847815\ \(0\)\
\-\ used\\:\\ 0\\.006116015218186496\ \(0\)\
\-\ management\\:\\ 0\\.006015916872118734\ \(0\)\
\-\ greater\\:\\ 0\\.005988276786698696\ \(0\)\
\-\ which\\:\\ 0\\.0059520320419498085\ \(0\)\
\-\ year\\-old\\:\\ 0\\.005855904144959359\ \(0\)\
\-\ ap\\:\\ 0\\.005830520465750817\ \(0\)\
\-\ early\\:\\ 0\\.005830520465750817\ \(0\)\
\-\ male\\:\\ 0\\.005765692305550273\ \(0\)\
\-\ they\\:\\ 0\\.00574430247478975\ \(0\)\
\-\ 20\\:\\ 0\\.005732304545069059\ \(0\)\
\-\ weight\\:\\ 0\\.005714451091680718\ \(0\)\
\-\ side\\:\\ 0\\.005523221085380729\ \(0\)\
\-\ presentation\\:\\ 0\\.005491419094199781\ \(0\)\
\-\ for\\:\\ 0\\.005441105586885934\ \(0\)\
\-\ of\\:\\ 0\\.005433945932741998\ \(0\)\
\-\ although\\:\\ 0\\.005384196418986201\ \(0\)\
\-\ possible\\:\\ 0\\.00536936981135088\ \(0\)\
\-\ available\\:\\ 0\\.005359550464253353\ \(0\)\
\-\ swelling\\:\\ 0\\.005311214298472262\ \(0\)\
\-\ initial\\:\\ 0\\.0052828025061181115\ \(0\)\
\-\ radiation\\:\\ 0\\.005231812032765553\ \(0\)\
\-\ plain\\:\\ 0\\.005177730807255755\ \(0\)\
\-\ superior\\:\\ 0\\.0050909397333100586\ \(0\)\
\-\ often\\:\\ 0\\.005086704381566515\ \(0\)\
\-\ and\\:\\ 0\\.005037565458924024\ \(0\)\
\-\ will\\:\\ 0\\.004987837720856608\ \(0\)\
\-\ such\\:\\ 0\\.004983829831792635\ \(0\)\
\-\ medical\\:\\ 0\\.0049054287314664255\ \(0\)\
\-\ clinical\\:\\ 0\\.0049054287314664255\ \(0\)\
\-\ age\\:\\ 0\\.0048524446372095265\ \(0\)\
\-\ some\\:\\ 0\\.004841284055721566\ \(0\)\
\-\ no\\:\\ 0\\.0048159187539391895\ \(0\)\
\-\ patient\\:\\ 0\\.004794357822293216\ \(0\)\
\-\ renal\\:\\ 0\\.004790066323615801\ \(0\)\
\-\ neck\\:\\ 0\\.004681423763094184\ \(0\)\
\-\ loss\\:\\ 0\\.004627731665053059\ \(0\)\
\-\ syndrome\\:\\ 0\\.004559527195400451\ \(0\)\
\-\ head\\:\\ 0\\.004521644236145328\ \(0\)\
\-\ time\\:\\ 0\\.0045029873642524485\ \(0\)\
\-\ history\\:\\ 0\\.004403785588459266\ \(0\)\
\-\ high\\:\\ 0\\.004362959069173163\ \(0\)\
\-\ if\\:\\ 0\\.0043260138689937225\ \(0\)\
\-\ significant\\:\\ 0\\.004287028266892208\ \(0\)\
\-\ cyst\\:\\ 0\\.004284274507511386\ \(0\)\
\-\ therapy\\:\\ 0\\.004262389545225024\ \(0\)\
\-\ due\\:\\ 0\\.004254248419688134\ \(0\)\
\-\ than\\:\\ 0\\.004177329953205734\ \(0\)\
\-\ these\\:\\ 0\\.004148963977533284\ \(0\)\
\-\ both\\:\\ 0\\.0040712686393397785\ \(0\)\
\-\ to\\:\\ 0\\.0039838442951771105\ \(0\)\
\-\ acute\\:\\ 0\\.003936342031915103\ \(0\)\
\-\ consistent\\:\\ 0\\.003909138561252245\ \(0\)\
\-\ increased\\:\\ 0\\.0039001581749993574\ \(0\)\
\-\ surgery\\:\\ 0\\.003871266911119916\ \(0\)\
\-\ 1\\:\\ 0\\.0037935193432084083\ \(0\)\
\-\ 3\\:\\ 0\\.0037331632960942904\ \(0\)\
\-\ demonstrate\\:\\ 0\\.0036687539950243297\ \(0\)\
\-\ can\\:\\ 0\\.00361608647848707\ \(0\)\
\-\ this\\:\\ 0\\.0035863328855004965\ \(0\)\
\-\ it\\:\\ 0\\.0035836723592033892\ \(0\)\
\-\ left\\:\\ 0\\.0035675569748989354\ \(0\)\
\-\ large\\:\\ 0\\.0034860866265505218\ \(0\)\
\-\ had\\:\\ 0\\.0034400183194789333\ \(0\)\
\-\ 2\\:\\ 0\\.0034330307770719143\ \(0\)\
\-\ findings\\:\\ 0\\.003393352492145447\ \(0\)\
\-\ treatment\\:\\ 0\\.003226897312688222\ \(0\)\
\-\ that\\:\\ 0\\.002753695389102282\ \(0\)\
\-\ from\\:\\ 0\\.002362753196183232\ \(0\)\
\-\ an\\:\\ 0\\.002204598627396884\ \(0\)\
\-\ or\\:\\ 0\\.0018685125913502005\ \(0\)\
\-\ was\\:\\ 0\\.0018438013474135948\ \(0\)\
\-\ \\.\\:\\ 0\\.001788222900426025\ \(0\)\
\-\ right\\:\\ 0\\.0016821487110268967\ \(0\)\
\-\ with\\:\\ 0\\.0015280396131142316\ \(0\)\
